Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Navigating peptide hype vs. evidence

“Peptides” have become a hot topic in the wellness industry and on social media. Interest recently spiked after HHS Secretary RFK Jr. announced a push to loosen federal…

DO
By Daniel Okafor · Regulatory Correspondent

From the source

Navigating peptide hype vs. evidence

“Peptides” have become a hot topic in the wellness industry and on social media. Interest recently spiked after HHS Secretary RFK Jr. announced a push to loosen federal restrictions on a group of peptides, making it easier for compounding pharmacies to prepare them. Most of these peptides are currently labeled “research use only” and cannot legally be prescribed.

Read at acsh.org
PeptiPrescribed peptides from $99/moSee all →